Glenmede Trust Co. NA Sells 9,555 Shares of CME Group Inc. (NASDAQ:CME)

Glenmede Trust Co. NA lowered its stake in CME Group Inc. (NASDAQ:CME) by 8.5% in the third quarter, HoldingsChannel.com reports. The firm owned 102,513 shares of the financial services provider’s stock after selling 9,555 shares during the quarter. Glenmede Trust Co. NA’s holdings in CME Group were worth $22,619,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of CME. Truvestments Capital LLC bought a new stake in shares of CME Group during the third quarter worth $26,000. Y.D. More Investments Ltd acquired a new stake in CME Group in the second quarter worth about $36,000. McClarren Financial Advisors Inc. raised its holdings in CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares during the last quarter. Asset Dedication LLC lifted its position in CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. boosted its stake in shares of CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 12.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,621 shares of company stock valued at $3,441,063. 0.30% of the stock is owned by insiders.

CME Group Stock Performance

Shares of CME stock opened at $237.33 on Thursday. The stock has a market cap of $85.52 billion, a P/E ratio of 24.96, a P/E/G ratio of 5.29 and a beta of 0.55. The company has a fifty day moving average price of $224.60 and a two-hundred day moving average price of $211.56. CME Group Inc. has a one year low of $190.70 and a one year high of $238.12. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. CME Group’s revenue was up 18.4% on a year-over-year basis. During the same period last year, the business posted $2.25 EPS. As a group, equities analysts predict that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 1.94%. CME Group’s dividend payout ratio is currently 48.37%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on CME. Citigroup boosted their price target on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research note on Thursday, October 24th. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target on the stock. in a research note on Tuesday, October 8th. Oppenheimer lifted their price objective on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. TD Cowen began coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price on the stock. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research report on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $224.47.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.